These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 20067336

  • 1. Population pharmacokinetics and pharmacodynamics of cinaciguat, a soluble guanylate cyclase activator, in patients with acute decompensated heart failure.
    Mueck W, Frey R.
    Clin Pharmacokinet; 2010; 49(2):119-29. PubMed ID: 20067336
    [Abstract] [Full Text] [Related]

  • 2. Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynamics in patients with acute decompensated heart failure.
    Lapp H, Mitrovic V, Franz N, Heuer H, Buerke M, Wolfertz J, Mueck W, Unger S, Wensing G, Frey R.
    Circulation; 2009 Jun 02; 119(21):2781-8. PubMed ID: 19451356
    [Abstract] [Full Text] [Related]

  • 3. A novel soluble guanylate cyclase activator with reduced risk of hypotension by short-acting vasodilation.
    Sawabe T, Chiba T, Kobayashi A, Nagasaka K, Aihara K, Takaya A.
    Pharmacol Res Perspect; 2019 Apr 02; 7(2):e00463. PubMed ID: 30873284
    [Abstract] [Full Text] [Related]

  • 4. Cinaciguat, a soluble guanylate cyclase activator, unloads the heart but also causes hypotension in acute decompensated heart failure.
    Erdmann E, Semigran MJ, Nieminen MS, Gheorghiade M, Agrawal R, Mitrovic V, Mebazaa A.
    Eur Heart J; 2013 Jan 02; 34(1):57-67. PubMed ID: 22778174
    [Abstract] [Full Text] [Related]

  • 5. Assessment of the effects of renal impairment on the pharmacokinetics of the soluble guanylate cyclase activator cinaciguat after a single intravenous dose.
    Lettieri JT, Scheerans C, Blunck M, Mazzu AL, Frey R, Mück W, Sundaresan PR.
    J Clin Pharmacol; 2012 Aug 02; 52(8):1240-7. PubMed ID: 21868716
    [Abstract] [Full Text] [Related]

  • 6. Pharmacokinetics, pharmacodynamics, tolerability, and safety of the soluble guanylate cyclase activator cinaciguat (BAY 58-2667) in healthy male volunteers.
    Frey R, Mück W, Unger S, Artmeier-Brandt U, Weimann G, Wensing G.
    J Clin Pharmacol; 2008 Dec 02; 48(12):1400-10. PubMed ID: 18779378
    [Abstract] [Full Text] [Related]

  • 7. Cinaciguat, a soluble guanylate cyclase activator for the potential treatment of acute heart failure.
    Tamargo J, Duarte J, Caballero R, Delpón E.
    Curr Opin Investig Drugs; 2010 Sep 02; 11(9):1039-47. PubMed ID: 20730699
    [Abstract] [Full Text] [Related]

  • 8. Cinaciguat, a soluble guanylate cyclase activator: results from the randomized, controlled, phase IIb COMPOSE programme in acute heart failure syndromes.
    Gheorghiade M, Greene SJ, Filippatos G, Erdmann E, Ferrari R, Levy PD, Maggioni A, Nowack C, Mebazaa A, COMPOSE Investigators and Coordinators.
    Eur J Heart Fail; 2012 Sep 02; 14(9):1056-66. PubMed ID: 22713287
    [Abstract] [Full Text] [Related]

  • 9. Pharmacokinetics of the soluble guanylate cyclase activator cinaciguat in individuals with hepatic impairment.
    Frey R, Scheerans C, Blunck M, Mück W, Gnoth MJ, Unger S, Schmidt A, Wensing G.
    J Clin Pharmacol; 2012 Nov 02; 52(11):1714-24. PubMed ID: 22162535
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Targeting heme-oxidized soluble guanylate cyclase in experimental heart failure.
    Boerrigter G, Costello-Boerrigter LC, Cataliotti A, Lapp H, Stasch JP, Burnett JC.
    Hypertension; 2007 May 02; 49(5):1128-33. PubMed ID: 17325237
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.